Skip to main content
OpenTrials

Clinical trial condition

Lung Neoplasms

Explore clinical trials studying Lung Neoplasms. Study availability and eligibility vary by location and protocol.

4,211 public trials 1,007 recruiting studies
Refine in advanced search Browse all conditions

Lung Neoplasms trial results

Active, Not Recruiting

Safety and Tolerability of IPH4502 in Patients With Advanced Solid Tumors

NCT06781983

Conditions
Adnexal Diseases, Advanced or Metastatic Solid Tumors, Breast Diseases, +64 more
Locations
  • Massachusetts General Hospital - Boston Boston, Massachusetts, United States
  • John Theurer Cancer Center Hackensack, New Jersey, United States
  • Mount Sinai Tisch Cancer Center New York, United States
  • NEXT Oncology - Dallas Dallas, Texas, United States
View Trial Details
Active, Not Recruiting

Circulating DNA to Improve Outcome of Oncology PatiEnt. A Randomized Study

NCT04258137

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +22 more
Locations
  • Centre hospitalier de la Côte Basque Bayonne, France
  • Clinique Tivoli-Ducos Bordeaux, France
  • Institut Bergonie Bordeaux, France
  • Polyclinique Bordeaux Nord Aquitaine Bordeaux, France
View Trial Details
Active, Not Recruiting

DAREON™-9: A Study to Test How Well Different Doses of BI 764532 Are Tolerated by People With Small Cell Lung Cancer When Taken Together With a Single Agent Chemotherapy

NCT05990738

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
Locations
  • MedStar Georgetown University Hospital Washington D.C., District of Columbia, United States
  • Mayo Clinic - Florida Jacksonville, Florida, United States
  • University of Miami Miami, Florida, United States
  • Virginia Commonwealth University Richmond, Virginia, United States
View all 14 locations
View Trial Details
Active, Not Recruiting

Plasma-Adapted First-Line Pembro In NSCLC

NCT04166487

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • Brigham and Women's Hospital Boston, Massachusetts, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Boston Medical Center Boston, Massachusetts, United States
  • Dana-Farber at Steward St. Elizabeth's Medical Center Brighton, Massachusetts, United States
View Trial Details
Active, Not Recruiting

A Phase 2 Study of Tarlatamab in Patients With Small Cell Lung Cancer (SCLC)

NCT05060016

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Christiana Care Health Services Newark, Delaware, United States
  • Moffitt Cancer Center Tampa, Florida, United States
View all 80 locations
View Trial Details
Active, Not Recruiting

Efficacy and Safety Study of Tisotumab Vedotin for Patients With Solid Tumors

NCT03485209

Conditions
Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +28 more
Locations
  • UCSD Medical Center - Encinitas Encinitas, California, United States
  • UC San Diego Medical Center - La Jolla (Jacobs Medical Center / Thornton Pavilion) La Jolla, California, United States
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • UCSD Koman Family Outpatient Pavilion La Jolla, California, United States
View all 175 locations
View Trial Details

Related conditions